Dr. Agarwal’s Health Care Limited’s Board of Directors has approved the effectiveness of its Scheme of Amalgamation with Dr. Agarwal’s Eye Hospital Limited. The scheme, sanctioned by the NCLT, will become effective on November 1, 2026, with an appointed date of April 1, 2026. The authorized share capital will be altered, and a record date of November 18, 2026, has been fixed for the allotment of consideration shares.
Scheme of Amalgamation Becomes Effective
Dr. Agarwal’s Health Care Limited has announced that its Board of Directors, during a meeting held on October 20, 2026, has officially noted, considered, and approved the effectiveness of the Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited. This significant corporate action is being undertaken under the provisions of the Companies Act, 2013.
Key Dates and Share Capital Changes
Following the receipt of the certified Order from the Hon’ble National Company Law Tribunal (NCLT), Chennai Bench, dated September 30, 2026, and the subsequent filing of the Order with the Registrar of Companies (ROC) on October 15, 2026, all stipulated conditions have been met. Consequently, the Scheme of Amalgamation is set to become effective and operative from November 1, 2026 (the Effective Date). The Appointed Date for the scheme is fixed as April 1, 2026.
The authorized share capital of the company will undergo alteration. The existing authorized share capital of Dr. Agarwal’s Eye Hospital Limited, comprising 2,00,00,000 Equity Shares of ₹10 each, has been reclassified into 20,00,00,000 Equity Shares of ₹1 each. Upon the Scheme’s effectiveness, this reclassified capital will be automatically merged with the existing authorized share capital of Dr. Agarwal’s Health Care Limited.
| Authorised Share Capital of Dr. Agarwal’s Health Care Limited (Transferee Company) (Prior to effectiveness of the Scheme) | INR |
| a) 54,20,00,000 Equity shares of INR 1 each | 54,20,00,000/- |
| b) 35,80,000 fully and compulsorily convertible non-cumulative participating preference shares of INR 100 each | 35,80,00,000/- |
| TOTAL | 90,00,00,000/- |
| Authorised Share Capital of Dr. Agarwal’s Health Care Limited (Transferee Company) (Post effectiveness of the Scheme) | INR |
| a) 74,20,00,000 Equity shares of INR 1 each | 74,20,00,000/- |
| b) 35,80,000 fully and compulsorily convertible non-cumulative participating preference shares of INR 100 each | 35,80,00,000/- |
| TOTAL | 110,00,00,000/- |
Record Date for Share Allotment
In accordance with the Scheme of Amalgamation and regulatory requirements, the Board of Directors has fixed Wednesday, November 18, 2026, as the Record Date. This date will be used to determine the eligible equity shareholders of Dr. Agarwal’s Eye Hospital Limited who are entitled to receive consideration shares. The approved Share Exchange Ratio is 23 fully paid-up Equity Shares of ₹1 each of Dr. Agarwal’s Health Care Limited for every 2 fully paid-up Equity Shares of ₹10 each held in Dr. Agarwal’s Eye Hospital Limited.
Source: BSE
